company background image
PEYE

Precision Optics Corporation OTCPK:PEYE Stock Report

Last Price

US$1.90

Market Cap

US$32.1m

7D

-4.0%

1Y

10.5%

Updated

05 May, 2022

Data

Company Financials
PEYE fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

PEYE Stock Overview

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area.

Precision Optics Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Precision Optics Corporation
Historical stock prices
Current Share PriceUS$1.90
52 Week HighUS$3.00
52 Week LowUS$1.52
Beta0.47
1 Month Change-5.00%
3 Month Change-7.77%
1 Year Change10.47%
3 Year Change27.52%
5 Year Change322.22%
Change since IPO-99.73%

Recent News & Updates

Shareholder Returns

PEYEUS Medical EquipmentUS Market
7D-4.0%-3.5%-3.3%
1Y10.5%-14.0%-8.1%

Return vs Industry: PEYE exceeded the US Medical Equipment industry which returned -11.5% over the past year.

Return vs Market: PEYE exceeded the US Market which returned -4.3% over the past year.

Price Volatility

Is PEYE's price volatile compared to industry and market?
PEYE volatility
PEYE Average Weekly Movement7.6%
Medical Equipment Industry Average Movement9.3%
Market Average Movement7.5%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market2.8%

Stable Share Price: PEYE is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: PEYE's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198251Joe Forkeyhttps://www.poci.com

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies, which are designed for industrial and military use.

Precision Optics Corporation Fundamentals Summary

How do Precision Optics Corporation's earnings and revenue compare to its market cap?
PEYE fundamental statistics
Market CapUS$32.14m
Earnings (TTM)-US$973.99k
Revenue (TTM)US$11.36m

2.8x

P/S Ratio

-33.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PEYE income statement (TTM)
RevenueUS$11.36m
Cost of RevenueUS$8.00m
Gross ProfitUS$3.36m
Other ExpensesUS$4.34m
Earnings-US$973.99k

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.058
Gross Margin29.59%
Net Profit Margin-8.57%
Debt/Equity Ratio27.3%

How did PEYE perform over the long term?

See historical performance and comparison

Valuation

Is Precision Optics Corporation undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


3.5x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate PEYE's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate PEYE's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: PEYE is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: PEYE is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate PEYE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: PEYE is overvalued based on its PB Ratio (3.5x) compared to the US Medical Equipment industry average (2.7x).


Future Growth

How is Precision Optics Corporation forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.5%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Precision Optics Corporation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Precision Optics Corporation performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


1.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: PEYE is currently unprofitable.

Growing Profit Margin: PEYE is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: PEYE is unprofitable, but has reduced losses over the past 5 years at a rate of 1.2% per year.

Accelerating Growth: Unable to compare PEYE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PEYE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (23%).


Return on Equity

High ROE: PEYE has a negative Return on Equity (-10.6%), as it is currently unprofitable.


Financial Health

How is Precision Optics Corporation's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: PEYE's short term assets ($6.4M) exceed its short term liabilities ($4.6M).

Long Term Liabilities: PEYE's short term assets ($6.4M) exceed its long term liabilities ($3.1M).


Debt to Equity History and Analysis

Debt Level: PEYE's net debt to equity ratio (13.6%) is considered satisfactory.

Reducing Debt: PEYE's debt to equity ratio has increased from 0% to 27.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PEYE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: PEYE has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 5.1% each year.


Dividend

What is Precision Optics Corporation current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate PEYE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PEYE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PEYE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PEYE's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PEYE has not reported any payouts.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.9yrs

Average management tenure


CEO

Joe Forkey (53 yo)

11.25yrs

Tenure

US$440,909

Compensation

Dr. Joseph N. Forkey, also known as Joe, has been Chief Executive Officer, President and Treasurer of Precision Optics Corp., Inc., since February 8, 2011. Dr. Forkey has been a Director at Precision Optic...


CEO Compensation Analysis

Compensation vs Market: Joe's total compensation ($USD440.91K) is below average for companies of similar size in the US market ($USD726.26K).

Compensation vs Earnings: Joe's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: PEYE's management team is considered experienced (2.9 years average tenure).


Board Members

Experienced Board: PEYE's board of directors are considered experienced (9.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.2%.


Top Shareholders

Company Information

Precision Optics Corporation, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Precision Optics Corporation, Inc.
  • Ticker: PEYE
  • Exchange: OTCPK
  • Founded: 1982
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$32.139m
  • Shares outstanding: 16.92m
  • Website: https://www.poci.com

Number of Employees


Location

  • Precision Optics Corporation, Inc.
  • 22 East Broadway
  • Gardner
  • Massachusetts
  • 1440
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/05 00:00
End of Day Share Price2022/05/05 00:00
Earnings2021/12/31
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.